FOSUN PHARMA
60019623.011.72% ( +0.39 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: FOSUN PHARMA(600196) predict that the Revenue is 9.999 B (+6.14%), Beat estimate;the EBIT is 1.375 B (+1.22%), Beat estimate;the EPS is 0.33 (+13.79%), Meet estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
10.00B6.14%
9.84B4.50%
+0.15B1.64%
EBITExceed expectations
1.38B1.22%
0.87B35.75%
+0.50B36.97%
EPS
0.3313.79%
0.3313.79%
0.00000.00%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf